tiprankstipranks
Catalyst Pharmaceuticals reports Q3 non-GAAP EPS 57c, consensus 30c
PremiumThe FlyCatalyst Pharmaceuticals reports Q3 non-GAAP EPS 57c, consensus 30c
1M ago
Catalyst Pharmaceuticals sees FY24 revenue $475M-$485M, consensus $473.67M
Premium
The Fly
Catalyst Pharmaceuticals sees FY24 revenue $475M-$485M, consensus $473.67M
1M ago
CPRX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CPRX Upcoming Earnings Report: What to Expect?
2M ago
Catalyst Pharmaceuticals price target raised to $30 from $25 at Truist
PremiumThe FlyCatalyst Pharmaceuticals price target raised to $30 from $25 at Truist
4M ago
Catalyst Pharmaceuticals price target raised to $31 from $27 at Citi
Premium
The Fly
Catalyst Pharmaceuticals price target raised to $31 from $27 at Citi
4M ago
Catalyst Pharmaceuticals backs FY24 revenue view $455M-$475M,
Premium
The Fly
Catalyst Pharmaceuticals backs FY24 revenue view $455M-$475M,
5M ago
Catalyst receives FDA approval for increased maximum daily dose for FIRDAPSE
PremiumThe FlyCatalyst receives FDA approval for increased maximum daily dose for FIRDAPSE
7M ago
Catalyst Pharmaceuticals price target raised to $26 from $24 at H.C. Wainwright
Premium
The Fly
Catalyst Pharmaceuticals price target raised to $26 from $24 at H.C. Wainwright
7M ago
Catalyst Pharmaceutical’s Buyback: A Double-Edged Sword for Financial Health and R&D Investment?
Premium
Company Announcements
Catalyst Pharmaceutical’s Buyback: A Double-Edged Sword for Financial Health and R&D Investment?
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100